Medical laboratories
Ended Awarded Last action
- Contract number
- W90VN622F5030
- Awardee
-
Seoul Clinical Laboratories UEI E961H2AE4AN5
- Awarding agency
-
RCO Osan 411th CSB
Expeditionary Contracting Command, Department of Defense
- Obligated
- $5,484
Award facts
- Contract value 4% obligated
-
- $5,483.52 Current, with exercised options
- $150,000.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Pacific Air Forces Air Force, Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
About this award
This contract award is for medical laboratory services provided to the U.S. Pacific Air Forces (PACAF), a major command of the U.S. Air Force. The prime contractor, Seoul Clinical Laboratories, is a for-profit research institute located in South Korea that specializes in clinical laboratory testing and diagnostic services.
The $150,000 firm-fixed-price contract, awarded on March 1, 2022, is a Blanket Purchase Agreement (BPA) call for medical laboratory services to support U.S. military healthcare operations in South Korea, with a period of performance through February 28, 2026. Seoul Clinical Laboratories has extensive experience providing a wide range of laboratory services, including COVID-19 testing, to U.S. military treatment facilities in the region. The contract does not have a set-aside designation.
Seoul Clinical Laboratories has received multiple contract awards and task orders from various Department of Defense agencies, including the Army Medical Command, Defense Health Agency, and PACAF, to deliver clinical laboratory services at U.S. military sites in South Korea. The company also holds several larger indefinite delivery vehicles with the Army and Air Force for COVID-19 testing and routine pathology services valued at up to $11.3 million and $250,000, respectively.
Quick answers
Who was awarded contract W90VN622F5030?
W90VN622F5030 was awarded to Seoul Clinical Laboratories by RCO Osan 411th CSB (Expeditionary Contracting Command) on March 1, 2022.
How much is contract W90VN622F5030 worth?
The government has obligated $5,484 on W90VN622F5030. Its potential value, with all options, is $150,000.
Which agency awarded contract W90VN622F5030?
RCO Osan 411th CSB (Expeditionary Contracting Command) awarded W90VN622F5030, with funding from Pacific Air Forces (Air Force).
Is contract W90VN622F5030 an order under another contract?
Yes. W90VN622F5030 is a BPA call under W90VN621A0006, a blanket purchase agreement.
Was contract W90VN622F5030 competed?
The extent of competition for W90VN622F5030 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award